Last edition
News about "Gennova Biopharmaceuticals Ltd Pune "
India's first mRNA-based vaccine, HGCO19 gets DCGI nod for phase II/III trial
Gennova Biopharmaceuticals Ltd., the Pune-based biotechnology company, submitted the interim clinical data of the phase I study to the Central Drugs Standard Control Organisation (CDSCO), the Government of India's National Regulatory Authority (NRA)
Gennova Biopharmaceuticals Ltd Pune | 24/08/2021 | By Darshana | 366
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members